QNST posts

Feed

Analyst Calls: BBY, BWA, DGI, EOG, M, MAC, MR, NOC, TXN, WFMI ...

Analyst Upgrades

  • Goldman believes EOG Resources (EOG) can regain its premium multiple given its ability to find new horizontal liquids resource plays. The firm upgraded shares to conviction buy from buy and has a $129 price target on the stock.
  • Deutsche Bank upgraded Macerich (MAC) to buy from hold following the company's Q2 results and raised its target for shares to $47 from $45.
  • Needham upgraded QuinStreet (QNST) to strong buy from buy, citing the strong Q4 report and valuation, and has a $20 target on the stock.
  • Macy's (M) was upgraded to buy from neutral at BofA/Merrill.
  • Whole Foods (WFMI) was upgraded to buy from neutral at UBS.
  • Texas Instruments (TXN) was upgraded to outperform from market perform at Raymond James.

Continue reading Analyst Calls: BBY, BWA, DGI, EOG, M, MAC, MR, NOC, TXN, WFMI ...

Analyst Calls: AFFY, AMLN, CACC, LAZ, LII, NKA, NRGY, OPEN, PANL, PEG ...

Analyst Upgrades

  • SunTrust upgraded Lennox (LII) to buy from neutral, given signs of improved residential HVAC equipment and service demand and a bottom in commercial lines. The firm has a $55 price target on the stock.
  • Cowen upgraded Universal Display (PANL) to outperform from neutral. The firm expects OLED display growth to accelerate driven by increased handset and other mobile device penetration, followed by high-end TV and lighting applications.
  • Canaccord upgraded Amylin (AMLN) to hold from sell following Roche's (RHHBY) delay in its Phase 3 study for taspo, a competitor to Amylin's bydureon. The firm has an $18 target on Amylin shares.
  • DiamondRock Hospitality (DRH) was upgraded to buy from hold at Citigroup.
  • Public Service (PEG) was upgraded to conviction buy from buy at Goldman.
  • QuinStreet (QNST) was upgraded to overweight on valuation at Thomas Weisel.

Continue reading Analyst Calls: AFFY, AMLN, CACC, LAZ, LII, NKA, NRGY, OPEN, PANL, PEG ...

Anthera Gets an IPO Infusion

It was not easy but Anthera Pharmaceuticals (ANTH) pulled off its IPO. However, the deal turned out to be fairly small. The company issued six million shares at $7 a piece. The original price range was $13 to $15.

But Anthera is not an isolated event; that is, it's been tough for any type of IPO. So far this year, a variety of companies have canceled their offerings or had to reduce the deal sizes, such as with Graham Packaging (GRM) and QuinStreet (QNST).

Continue reading Anthera Gets an IPO Infusion

Symbol Lookup
IndexesChangePrice
DJIA-74.9212,454.83
NASDAQ-1.852,837.53
S&P 500-2.861,317.82

Last updated: May 27, 2012: 01:36 PM

Hot Stocks

General Electric

19.20-0.05(-0.26)

Alcoa

8.630.00(0.00)

Apple Inc

562.29-3.03(-0.54)

Google Inc 'A'

591.53-12.13(-2.01)

Bank of America

7.15+0.01(+0.14)

Wal-Mart Stores

65.31+0.24(+0.37)

Exxon Mobil Corp

82.08-0.53(-0.64)

Ford

10.60+0.01(+0.09)

Citigroup

26.47-0.19(-0.71)

IBM

194.30-1.79(-0.91)

Yahoo

15.36+0.01(+0.07)

Starbucks

54.56-0.20(-0.37)

Microsoft

29.06-0.01(-0.03)

Home Depot

49.44-0.27(-0.54)

DailyFinance Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

Page Loaded in 1338140200239 ms.